potential bull run to the Q3 earnings

업데이트됨
The news are great, the fundamentals better than ever, but the stock is dropping.

WHY?

스냅샷
The big reason is, that big money wants to buy your share before the next bull run.
Therefore they try to push the price into liquidity zones where a lot of Stop/Losses are triggered.
250€ and 200€ are important Fibonacci targets which act like magnets.

Bull Case:
스냅샷
스냅샷
These are the current support zones.

If we assume that we have a finished Elliott Wave, than 250€ could be a support with the 0.618 Fibonacci Retracment.

스냅샷
This is the current Elliott Wave count, eventhough it's not quite perfect. Ignoring some minor flaws, it's still intact.

If we do a normal extention than we could have a first target nearby 600€ (700$) and 800€ (903$) for the long term.
(bear in mind that there could be an overthrow due to the hype in a parabolic movement)

Are 600€ even possible?
Fundamentally, Yes. Technically, Yes.
We had a 144% gain on the last run to the Q2 earnings which we need now for a 600€ target.
스냅샷

What are the risk?
스냅샷
If the Elliott Wave isn't correct, than we could drop even further to the bigger correction nearby 200€.
스냅샷

스냅샷

The current sentiment is extremely cautious due to the Evergrand situation. It's all about timing now if we hit the perfekt window.


PS: I'm just drawing lines. These charts are extremely speculativ. Do your own due dilligence!
노트
On the end of the last week we had the "black swan" news about the Merck corona pill.
Therefore, we saw the next drop to the next support level.

스냅샷
This was my TA before the big correction. (can be found on my last Idea update).
We dropped faster than expected, but the target was reached.

usd chart:
스냅샷
Now we are starting to see the first signs of a momentum shift.
The indicators are looking good, the supports are holding and we see a good buying force from our target.

The risk is still high and we could even drop to a range nearby 210 - 200$.
On the other hand this scenario is exactly what big money wants to see.
We have some good news coming up the next weeks and a potenial momentum shift is imminent.

The drop has lowered our upper Fibonacci target to 520€.
노트
스냅샷
노트
EUR 2D Chart:
스냅샷

USD Chart:
스냅샷

Risk:
스냅샷
노트
usd chart:
스냅샷
We are forming an ascending triangle at the moment. Normally a bullish pattern, although a triangle is a continuation pattern in general.
In our case, we are trying to breach the 260$ mark, which should fall if it gets hit a forth time.
The up movements were strong accompanied by high volume. In comparison, the downmovements were slowly and had low volume. This indicates an momentum shift with a increasing buying force.

Worst case scenario:
스냅샷
As I've mentioned above, a triangle is a continuation pattern.
We could drop if market makers still want to load up their shares. They seek for zones with high liquidiy and that could be found if a lot of Stop/Losses would be triggered.

Regarding the increasing buying power, the support of an important algo target and the timing before the Q3 report, I give this case something under 20%.
I'm still bullish.
노트
스냅샷

The bearish case should be over for now.
노트
스냅샷
As predicted, we started the bullish wave upwards and are hovering at point (4) at the moment. Eventhough we had the Novavax Fud, the uptrend is still intact.

4h timeframe usd chart:
스냅샷

15 min timeframe usd chart:
스냅샷

RSI analysis:
스냅샷

Risk:
스냅샷

Overall I'm still bullish until the Q3 ER and beyong, eventhough it becomes unlikey that we reach our longterm targets in time. Those targets are still intact, but will be delayed into the future.
노트
스냅샷

We are still bullish and have a high likelyhood of 333$ before the Q3 earnings now.
biontechBNTXChart PatternsTrend AnalysisWave Analysis

또한 다음에서도:

면책사항